Global Cellular Immunotherapy Market Report 2024

Cellular Immunotherapy Global Market Report 2024 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications ) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 175 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Cellular Immunotherapy Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Cellular Immunotherapy Market Definition And Segments

Cellular immunotherapy refers to a sort of immunotherapy in which a patient receives T cells, an immune cell, to aid the body in fighting diseases like cancer. It is a cutting-edge kind of treatment that uses the body's immune system to combat cancer.

The main therapies of cellular immunotherapy are tumor-infiltrating lymphocyte (TIL) therapy, engineered T cell receptor (TCR) therapy, chimeric antigen receptor (CAR) T cell therapy, and natural killer (NK) cell therapy. Tumor-infiltrating lymphocyte (TIL) therapy is a type of adoptive cellular therapy that involves extracting infiltrated lymphocytes from tumors, culturing and amplifying them in vitro, and then infusing them back into patients to treat them. The various primary indications include b-cell malignancies, prostate cancer, renal cell carcinoma, liver cancer, non-Hodgkin lymphoma, and others, and are used for the treatment of prostate cancer, breast cancer, skin cancer, ovarian cancer, brain tumors, lung cancer, and others.

The cellular immunotherapy market covered in this report is segmented –

1) By Therapy: Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy

2) By Primary Indication: B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications

3) By Application: Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications

The cellular immunotherapy market size has grown rapidly in recent years. It will grow from $4.99 billion in 2023 to $5.78 billion in 2024 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to cancer treatment advancements, clinical success stories, regulatory approvals, growing incidence of targeted diseases.

The cellular immunotherapy market size is expected to see rapid growth in the next few years. It will grow to $9.95 billion in 2028 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to expansion to solid tumors, improved manufacturing, healthcare infrastructure, research funding. Major trends in the forecast period include research and development investments, clinical trial data, combination therapies.

Expanding Cellular Immunotherapy Market Driven By Research And Clinical Advancements

Increasing research and successful clinical trials in cellular immunotherapy are expected to drive the growth of the cellular immunotherapy market over the forecast period. Companies are focusing on developing new cellular immunotherapies for treating different diseases. For instance, in June 2022, according to a report published by the Cancer Research Institute, a US-based nonprofit organization devoted solely to developing immunotherapy for the prevention, treatment, and eventual eradication of all cancers, in the worldwide immuno-oncology pipeline as of April 2022, there were 2,756 active cell therapy drugs, up 36% from the landscape analysis of 2021 that revealed 2,031 such agents but also a slight slowdown from the 43% growth in the previous year. The rapid growth in the development of cellular immunotherapy in clinical and preclinical stages in 2020 as compared to that in 2019 is projected to expand the landscape of cellular immunotherapy. Subsequently, generating higher revenues for the growth of the cellular immunotherapy market.

Role Of Cellular Immunotherapies In Addressing Rising Prevalence

The rising prevalence of cancer is expected to propel the growth of the cellular immunotherapies market going forward. Cancer is a term used to describe a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. Cancer has driven research and investment in cancer therapies, including cellular immunotherapies. Cellular immunotherapies are cancer treatments that employ the immune system of the body to combat cancer cells. These therapies employ immune cells extracted from the patient's body, amplified in a lab, and then reintroduced into the patient's body to assist the immune system detect and fight cancer cells. For instance, in 2021, according to American cancer society journal, estimated numbers of new cancer cases and deaths in 2021 (In 2021, there will likely be 608,570 cancer deaths in the United States and 1.9 million new cases of cancer diagnosed). Therefore, the rising prevalence of cancer is driving the growth of the cellular immunotherapy market.

Major companies operating in the cellular immunotherapy market include Novartis International AG, Gilead Sciences Inc., Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd., Green Cross Corp, AstraZeneca PLC, Bristol Myers Squibb Company, Pfizer Inc., F. Hoffmann-La Roche Ltd., Adicet Bio Inc., ResTORbio Inc., Celyad SA, Merck KGaA, GlaxoSmithKline plc., Johnson & Johnson, Adaptimmune Therapeutics PLC, AVROBIO Inc., Cellular Biomedicine Group Inc., Kite Pharma Inc., Juno Therapeutics Inc., Celgene Corporation, Bluebird Bio Inc., Tmunity Therapeutics Inc., Atara Biotherapeutics Inc., Fate Therapeutics Inc., Precision Biosciences Inc., Allogene Therapeutics Inc., CRISPR Therapeutics AG, Sangamo Therapeutics Inc., Intellia Therapeutics Inc., Editas Medicine Inc., Caribou Biosciences Inc., Mammoth Biosciences Inc., Synthego Corporation

Challenges To Cellular Immunotherapy Market Growth A Barrier Of High Treatment Costs

The high cost of cellular immunotherapies is anticipated to hinder cellular immunotherapy’s market growth. CAR-T therapy is a type of cellular immunotherapy and only two have been approved in the USA. The price of Yescarta and Kymriah is more than $350,000 per treatment in the USA, which is highly unaffordable for a majority of the patients, especially with low income. The high cost of cellular immunotherapies discourages patients to opt for this drug, thereby, impacting the demand and the market negatively.

Advancements In Cellular Immunotherapy A Rise Of Off-The-Shelf Allogeneic Therapies

Companies in the cellular immunotherapy market are focusing on developing off-the-shelf allogeneic therapies for new and improved cancer treatment. Off-the-shelf allogeneic therapies are produced from the cells of donors instead of the patient's cells, as in the case of autologous therapy. Their non-customized nature provides advantages such as cost-effectiveness, large scale, fast production, and quality control. For instance, in May 2022, Novartis AG, a Switzerland-based pharmaceutical company specializing in the discovery, development, manufacturing, and commercialization of drugs, announced that after two or more lines of systemic therapy, the US Food and Drug Administration (FDA) has given expedited approval for Kymriah (tisagenlecleucel) to treat adult patients with relapsed or refractory (r/r) follicular lymphoma (FL). In addition, Acepodia, a US-based next-generation cell immuno-technology company, will begin a phase 1 clinical trial in August 2020 to evaluate ACE1702, an allogeneic, off-the-shelf NK cell therapy, for the treatment of solid tumors.

Innovative Advancements In Cellular Immunotherapy An Emergence Of The T-Charge Platform

Major companies operating in cellular immunotherapy market are developing innovative new technologies, such as T-Charge to increase their profitability in the market. CAR-T cell therapy is a sort of cellular immunotherapy that fights cancer by using T cells that have undergone unique modifications. For instance, in December 2021, Novartis, a Switzerland-based pharmaceutical corporation, announced the introduction of T-Charge. The T-Charge platform maintains the stemness, self-renewal, and maturation capabilities of T cells, resulting in a product with more proliferative capacity and fewer tired T cells. This retention of T cell properties leads in a product with more proliferative ability and fewer fatigued T cells, thereby providing patients with a higher possibility of stronger and more persistent responses, superior long-term outcomes, and a lower risk of serious side effects.

Biontech's Strategic Acquisition Of Kite Pharma Expanding Capabilities In Cellular Immunotherapy

In August 2021, BioNTech, a German-based biotechnology company, acquired Kite Pharma, biotechnology company for an undisclosed amount. With this acquisition of Kite's laboratory and its unique TCR platform, BioNTech can increase its capabilities and hasten the creation of its extensive immunotherapy pipeline. Kite's customized solid tumor neoantigen TCR discovery platform and the Gaithersburg R&D and clinical production facility were acquired for a one-time upfront payment from BioNTech. Kite Pharma, a US-based biotechnology company that develops cancer immunotherapy products.

North America was the largest region in the cellular immunotherapy market in 2023. The regions covered in the cellular immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cellular immunotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The cellular immunotherapy market includes revenues earned by entities by inventing, developing, administering, and understanding engineered immune effector cells. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The cellular immunotherapy market research report is one of a series of new reports from The Business Research Company that provides cellular immunotherapy market statistics, including cellular immunotherapy industry global market size, regional shares, competitors with a cellular immunotherapy market share, detailed cellular immunotherapy market segments, market trends and opportunities, and any further data you may need to thrive in the cellular immunotherapy industry. This cellular immunotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Cellular Immunotherapy Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $5.78 billion
Revenue Forecast In 2033 $9.95 billion
Growth Rate CAGR of 14.6% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Therapy: Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy
2) By Primary Indication: B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications
3) By Application: Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Novartis International AG; Gilead Sciences Inc.; Apac Biotech; Dendreon Pharmaceuticals LLC; JW CreaGene Co. Ltd; Green Cross Corp; AstraZeneca plc; Bristol Myers Squibb Company; Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Adicet Bio Inc.; ResTORbio Inc.; Celyad SA; Merck KGaA; GlaxoSmithKline plc.; Johnson & Johnson; Adaptimmune Therapeutics plc; AVROBIO Inc.; Cellular Biomedicine Group Inc.; Kite Pharma Inc.; Juno Therapeutics Inc.; Celgene Corporation; Bluebird Bio Inc.; Tmunity Therapeutics Inc.; Atara Biotherapeutics Inc.; Fate Therapeutics Inc.; Precision Biosciences Inc.; Allogene Therapeutics Inc.; CRISPR Therapeutics AG; Sangamo Therapeutics Inc.; Intellia Therapeutics Inc.; Editas Medicine Inc.; Caribou Biosciences Inc.; Mammoth Biosciences Inc.; Synthego Corporation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Cellular Immunotherapy Market Characteristics

    3. Cellular Immunotherapy Market Trends And Strategies

    4. Cellular Immunotherapy Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Cellular Immunotherapy Market Size and Growth

    5.1. Global Cellular Immunotherapy Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Cellular Immunotherapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Cellular Immunotherapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Cellular Immunotherapy Market Segmentation

    6.1. Global Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Tumour-Infiltrating Lymphocyte (TIL) Therapy

    Engineered T Cell Receptor (TCR) Therapy

    Chimeric Antigen Receptor (CAR) T Cell Therapy

    Natural Killer (NK) Cell Therapy

    6.2. Global Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    B-Cell Malignancies

    Prostate Cancer

    Renal Cell Carcinoma

    Liver Cancer

    Non-Hodgkin lymphoma

    Other Primary Indications

    6.3. Global Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Prostate Cancer

    Breast Cancer

    Skin Cancer

    Ovarian Cancer

    Brain Tumour

    Lung Cancer

    Other Applications

    7. Cellular Immunotherapy Market Regional And Country Analysis

    7.1. Global Cellular Immunotherapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Cellular Immunotherapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Cellular Immunotherapy Market

    8.1. Asia-Pacific Cellular Immunotherapy Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Cellular Immunotherapy Market

    9.1. China Cellular Immunotherapy Market Overview

    9.2. China Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Cellular Immunotherapy Market

    10.1. India Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Cellular Immunotherapy Market

    11.1. Japan Cellular Immunotherapy Market Overview

    11.2. Japan Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Cellular Immunotherapy Market

    12.1. Australia Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Cellular Immunotherapy Market

    13.1. Indonesia Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Cellular Immunotherapy Market

    14.1. South Korea Cellular Immunotherapy Market Overview

    14.2. South Korea Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Cellular Immunotherapy Market

    15.1. Western Europe Cellular Immunotherapy Market Overview

    15.2. Western Europe Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Cellular Immunotherapy Market

    16.1. UK Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Cellular Immunotherapy Market

    17.1. Germany Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Cellular Immunotherapy Market

    18.5. France Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Cellular Immunotherapy Market

    19.9. Italy Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Cellular Immunotherapy Market

    20.13. Spain Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Cellular Immunotherapy Market

    21.1. Eastern Europe Cellular Immunotherapy Market Overview

    21.2. Eastern Europe Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Cellular Immunotherapy Market

    22.1. Russia Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Cellular Immunotherapy Market

    23.1. North America Cellular Immunotherapy Market Overview

    23.2. North America Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Cellular Immunotherapy Market

    24.1. USA Cellular Immunotherapy Market Overview

    24.2. USA Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Cellular Immunotherapy Market

    25.1. Canada Cellular Immunotherapy Market Overview

    25.2. Canada Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Cellular Immunotherapy Market

    26.1. South America Cellular Immunotherapy Market Overview

    26.2. South America Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Cellular Immunotherapy Market

    27.1. Brazil Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Cellular Immunotherapy Market

    28.1. Middle East Cellular Immunotherapy Market Overview

    28.2. Middle East Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Cellular Immunotherapy Market

    29.1. Africa Cellular Immunotherapy Market Overview

    29.2. Africa Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Cellular Immunotherapy Market Competitive Landscape And Company Profiles

    30.1. Cellular Immunotherapy Market Competitive Landscape

    30.2. Cellular Immunotherapy Market Company Profiles

    30.2.1. Novartis International AG

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Gilead Sciences Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Apac Biotech

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Dendreon Pharmaceuticals LLC

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. JW CreaGene Co. Ltd

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Cellular Immunotherapy Market Competitive Benchmarking

    32. Global Cellular Immunotherapy Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Cellular Immunotherapy Market

    34. Cellular Immunotherapy Market Future Outlook and Potential Analysis

    34.1 Cellular Immunotherapy Market In 2028 - Countries Offering Most New Opportunities

    34.2 Cellular Immunotherapy Market In 2028 - Segments Offering Most New Opportunities

    34.3 Cellular Immunotherapy Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Cellular Immunotherapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Cellular Immunotherapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Novartis International AG Financial Performance
  • Table 75: Gilead Sciences Inc. Financial Performance
  • Table 76: Apac Biotech Financial Performance
  • Table 77: Dendreon Pharmaceuticals LLC Financial Performance
  • Table 78: JW CreaGene Co. Ltd Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Cellular Immunotherapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Cellular Immunotherapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Novartis International AG Financial Performance
  • Figure 75: Gilead Sciences Inc. Financial Performance
  • Figure 76: Apac Biotech Financial Performance
  • Figure 77: Dendreon Pharmaceuticals LLC Financial Performance
  • Figure 78: JW CreaGene Co. Ltd Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Drugs for Immunotherapy Global Market Report 2024 – By Type (Monoclonal Antibodies, Interferons, Interleukins, Vaccines, Checkpoint Inhibitors, Other Types), By Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Other Therapy Areas), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Skin Cancer Drugs Global Market Report 2024 – By Type (Actinic Keratoses (AK), Basal cell carcinoma (BCC), Squamous cell carcinoma (SCC), Melanoma), By Drug Class (Chemotherapy, Immunotherapy, Targeted Agents & Other Drugs), By End Users (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Colorectal Cancer Drugs Global Market Report 2024 – By Type (Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL– Inhibitors, BRAF or MEK Inhibitors, Tyrosine Kinase (TKI) Inhibitors, Immunomodulators), By Class (Immunotherapy, Chemotherapy, Other Classes), By Distribution Channels (Hospitals Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Prostate Cancer Drugs Global Market Report 2024 – By Type (Hormone Sensitive Prostate Cancer, Hormone Refractory Prostate Cancer), By Therapy (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), By End User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Viral Vectors And Plasmid DNA Global Market Report 2024 – By Product (Plasmid DNA, Viral Vectors), By Disease (Infectious Diseases, Genetic Disorders, Cancer, Other Diseases), By Application (Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Other Applications), By End User (Research Institutes, Biopharmaceutical And Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Leukemia Therapeutics Global Market Report 2024 – By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Other Treatments), By Type Of Leukemia (Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Other Type Of Leukemia), By Molecule Type (Small Molecules, Biologics), By End-Users (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cancer Immunotherapy Global Market Report 2024 – By Product (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Multiple Myeloma), By End User (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2024-2033
View Report
3D Cell Culture Technologies Global Market Report 2024 – By Type (Scaffold-based, Scaffold-free, 3D Bioreactors), By Application (Cancer Research, Stem Cell Research, Drug Discovery, Regenerative Medicine), By End Users (Research Laboratories and Institutes, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the cellular immunotherapy market?

Cellular immunotherapy refers to a sort of immunotherapy in which a patient receives T cells, an immune cell, to aid the body in fighting diseases like cancer. It is a cutting-edge kind of treatment that uses the body's immune system to combat cancer. For further insights on the cellular immunotherapy market, request a sample here

How will the cellular immunotherapy market drivers and restraints affect the cellular immunotherapy market dynamics? What forces will shape the cellular immunotherapy industry going forward?

The cellular immunotherapy market major growth driver - expanding cellular immunotherapy market driven by research and clinical advancements. For further insights on the cellular immunotherapy market, request a sample here

What is the forecast market size or the forecast market value of the cellular immunotherapy market ?

The cellular immunotherapy market size has grown rapidly in recent years. It will grow from $4.99 billion in 2023 to $5.78 billion in 2024 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to cancer treatment advancements, clinical success stories, regulatory approvals, growing incidence of targeted diseases. The cellular immunotherapy market size is expected to see rapid growth in the next few years. It will grow to $9.95 billion in 2028 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to expansion to solid tumors, improved manufacturing, healthcare infrastructure, research funding. Major trends in the forecast period include research and development investments, clinical trial data, combination therapies. For further insights on the cellular immunotherapy market, request a sample here

How is the cellular immunotherapy market segmented?

The cellular immunotherapy market is segmented
1) By Therapy: Tumor-Infiltrating Lymphocyte (TIL) Therapy; Engineered T Cell Receptor (TCR) Therapy; Chimeric Antigen Receptor (CAR) T Cell Therapy; Natural Killer (NK) Cell Therapy
2) By Primary Indication: B-cell Malignancies; Prostate Cancer; Renal Cell Carcinoma; Liver Cancer; Non-Hodgkin lymphoma; Other Primary Indications
3) By Application: Prostate Cancer; Breast Cancer; Skin Cancer; Ovarian Cancer; Brain Tumor; Lung Cancer; Other Applications For further insights on the cellular immunotherapy market, request a sample here

Which region has the largest share of the cellular immunotherapy market? What are the other regions covered in the report?

North America was the largest region in the cellular immunotherapy market in 2023. The regions covered in the cellular immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the cellular immunotherapy market, request a sample here.

Who are the major players in the cellular immunotherapy market?

Major companies operating in the cellular immunotherapy market include Novartis International AG, Gilead Sciences Inc., Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd, Green Cross Corp, AstraZeneca plc, Bristol Myers Squibb Company, Pfizer Inc., F. Hoffmann-La Roche Ltd., Adicet Bio Inc., ResTORbio Inc., Celyad SA, Merck KGaA, GlaxoSmithKline plc., Johnson & Johnson, Adaptimmune Therapeutics plc, AVROBIO Inc., Cellular Biomedicine Group Inc., Kite Pharma Inc., Juno Therapeutics Inc., Celgene Corporation, Bluebird Bio Inc., Tmunity Therapeutics Inc., Atara Biotherapeutics Inc., Fate Therapeutics Inc., Precision Biosciences Inc., Allogene Therapeutics Inc., CRISPR Therapeutics AG, Sangamo Therapeutics Inc., Intellia Therapeutics Inc., Editas Medicine Inc., Caribou Biosciences Inc., Mammoth Biosciences Inc., Synthego Corporation For further insights on the cellular immunotherapy market, request a sample here.

What are the key trends in the cellular immunotherapy market?

Major trend in the cellular immunotherapy market - advancements in cellular immunotherapy a rise of off-the-shelf allogeneic therapies. For further insights on the cellular immunotherapy market, request a sample here.

What are the major opportunities in the cellular immunotherapy market? What are the strategies for the cellular immunotherapy market?

For detailed insights on the major opportunities and strategies in the cellular immunotherapy market, request a sample here.

How does the cellular immunotherapy market relate to the overall economy and other similar markets?

For detailed insights on cellular immunotherapy market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the cellular immunotherapy industry?

For detailed insights on the mergers and acquisitions in the cellular immunotherapy industry, request a sample here.

What are the key dynamics influencing the cellular immunotherapy market growth? SWOT analysis of the cellular immunotherapy market.

For detailed insights on the key dynamics influencing the cellular immunotherapy market growth and SWOT analysis of the cellular immunotherapy industry, request a sample here.